Candriam Equities L Biotech.I USD Acc/ LU0133360163 /
NAV2024-07-25 | Chg.+64.6602 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
6,255.2002USD | +1.04% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2010 | - | - | - | -1.92 | -12.43 | -5.63 | 3.72 | -0.39 | 10.81 | 2.77 | -2.49 | 6.27 | - |
2011 | -0.55 | 0.81 | 6.01 | 4.63 | 3.03 | -1.68 | -3.48 | -7.93 | -6.61 | 8.03 | 0.79 | 1.88 | +3.71% |
2012 | 11.93 | 0.47 | 5.85 | 0.64 | -2.06 | 5.60 | 2.44 | 2.00 | 5.23 | -5.87 | 4.49 | -0.94 | +32.74% |
2013 | 9.77 | 1.10 | 8.17 | 6.20 | 3.38 | -2.67 | 14.37 | -2.34 | 10.05 | -2.71 | 6.63 | 1.70 | +66.35% |
2014 | 8.34 | 7.43 | -9.86 | -5.01 | 2.85 | 10.21 | -3.16 | 11.16 | -1.01 | 9.50 | 2.94 | 0.54 | +36.44% |
2015 | 4.81 | 4.62 | 1.96 | -5.03 | 10.84 | 0.64 | 4.25 | -10.88 | -11.30 | 7.89 | 3.41 | 0.49 | +9.42% |
2016 | -23.19 | -4.51 | 3.72 | 3.59 | 5.36 | -8.22 | 12.56 | -2.43 | 3.84 | -12.36 | 8.72 | -2.84 | -19.55% |
2017 | 5.49 | 6.87 | -0.10 | 1.21 | -3.07 | 9.20 | 2.54 | 6.37 | 0.79 | -6.35 | 0.27 | 1.51 | +26.45% |
2018 | 6.86 | -4.68 | -1.91 | -3.10 | 4.66 | 0.96 | 4.81 | 4.27 | -2.01 | -13.94 | 4.21 | -8.55 | -10.16% |
2019 | 13.26 | 3.44 | -0.55 | -4.85 | -4.71 | 9.40 | -2.30 | -2.34 | -4.19 | 10.49 | 11.81 | 2.45 | +33.72% |
2020 | -5.13 | -1.12 | -4.98 | 12.87 | 9.33 | 1.41 | -2.75 | 0.93 | 0.67 | -2.80 | 9.83 | 3.11 | +21.31% |
2021 | 1.89 | -2.52 | -4.20 | 2.80 | -2.19 | 6.44 | -1.38 | 3.98 | -4.16 | 0.24 | -4.30 | 2.46 | -1.64% |
2022 | -10.78 | -1.97 | 5.73 | -7.56 | -3.34 | 3.06 | 4.62 | 1.14 | -1.89 | 6.92 | 6.13 | -2.78 | -2.50% |
2023 | 3.00 | -5.68 | 0.44 | 2.28 | -1.20 | 1.25 | -0.14 | -0.16 | -4.29 | -6.12 | 5.98 | 13.49 | +7.55% |
2024 | 1.34 | 1.36 | 0.06 | -6.12 | 4.15 | 5.39 | 5.88 | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 16.07% | 16.27% | 16.72% | 20.20% | 22.65% |
Sharpe ratio | 1.32 | 1.26 | 1.12 | 0.09 | 0.33 |
Best month | +13.49% | +6.99% | +13.49% | +13.49% | +13.49% |
Worst month | -6.12% | -6.12% | -6.12% | -10.78% | -10.78% |
Maximum loss | -10.97% | -10.97% | -12.26% | -29.30% | -30.63% |
Outperformance | -1.08% | - | -1.94% | +3.07% | +0.98% |
All quotes in USD
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Candriam Equities L Biotechnolog... | reinvestment | 2,286.9800 | +22.63% | +17.56% | |
Candriam Equities L Biotech.C EU... | reinvestment | 243.7100 | +23.94% | +27.10% | |
Candriam Equities L Biotech.I-H ... | reinvestment | 2,281.9399 | +20.02% | +9.12% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,456.6499 | +24.63% | +27.49% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,725.7200 | +22.30% | +24.47% | |
Candriam Equities L Biotech.R GB... | reinvestment | 391.8100 | +22.77% | +28.77% | |
Candriam Equities L Biotech.R EU... | reinvestment | 360.1900 | +25.10% | +30.50% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 221.7800 | +17.46% | +7.23% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 2,051.3999 | +23.27% | +20.87% | |
Candriam Equities L Biotechnolog... | reinvestment | 165.2000 | - | - | |
Candriam Equities L Biotech.N US... | reinvestment | 665.2100 | +21.44% | +15.58% | |
Candriam Equities L Biotech.I US... | reinvestment | 6,255.2002 | +22.48% | +17.13% | |
Candriam Equities L Biotech.C-H ... | reinvestment | 218.3800 | +19.44% | +8.94% | |
Candriam Equities L Biotech.R US... | reinvestment | 297.2000 | +22.96% | +19.96% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 228.0600 | +20.44% | +11.65% | |
Candriam Equities L Biotechnolo... | reinvestment | 934.3600 | +21.88% | +17.02% | |
Candriam Equities L Biotechnolog... | paying dividend | 853.2800 | +21.84% | +16.91% |
Performance
YTD | +13.32% | ||
---|---|---|---|
6 Months | +11.39% | ||
1 Year | +22.48% | ||
3 Years | +17.13% | ||
5 Years | +69.59% | ||
10 Years | +134.26% | ||
Since start | +525.52% | ||
Year | |||
2023 | +7.55% | ||
2022 | -2.50% | ||
2021 | -1.64% | ||
2020 | +21.31% | ||
2019 | +33.72% | ||
2018 | -10.16% | ||
2017 | +26.45% | ||
2016 | -19.55% | ||
2015 | +9.42% |